FPT Achieves 2024 EcoVadis Platinum Rating for Sustainability Through Its French Subsidiary
12.12.2024 08:24:00 CET | Business Wire | Press release
Global technology corporation FPT recently achieved the EcoVadis Platinum rating through its French subsidiary. This is the highest distinction in the survey conducted by EcoVadis, an international organization that evaluates corporate sustainability activities. The recognition places FPT in the top 1% of companies evaluated worldwide for their commitment to sustainable business practices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211227891/en/
(Graphic: Business Wire)
The EcoVadis rating is a comprehensive assessment of a company’s environmental, social, and governance (ESG) practices. It includes a global network of over 130,000 companies of various sizes across 220+ industries and 180+ countries. Sustainability performance is assessed across 21 criteria in four themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
FPT attained an overall score of 88/100, with impressive ratings of 90/100 for both Labor & Human Rights and Ethics, and 80/100 for the Environment category. This achievement reflects the company’s commitment to all dimensions of environmental policies, efficient corporate governance protocols, robust employee professional development initiatives, and dedication to reducing carbon emissions.
Mdm. Chu Thi Thanh Ha, Chairwoman of FPT Software, FPT Corporation, said: “FPT’s recognition by EcoVadis comes as part of our broader sustainability strategy, which includes embracing technologies, cultivating future-ready talents and driving new values that will last generations. Moving forward, we will continue to prioritize sustainability across all levels of our operations, with ongoing initiatives and investments to integrate sustainable practices into our solutions and services, as well as the work we deliver to our global customers.”
In 2023, FPT received a Silver rating from EcoVadis, further demonstrating its dedication to sustainable and ethical practices. In 2024, the company achieved ISO 45001 certification, the international standard for occupational health and safety, across its twelve campuses and offices in Vietnam, Germany, and France. Additionally, FPT won the Job Creation Award at ESGBusiness Awards 2024 and joined the Pledge 1% movement, reinforcing its dedication to corporate social responsibility and community engagement.
Since entering France in 2008, FPT has solidified its market position and demonstrated its expertise by collaborating with global leaders such as Airbus, La Poste, Air Liquide, Quadient, etc. In 2023, the French subsidiary entered France's top 100 ICT Companies. That same year, the company further strengthened its capabilities by acquiring an 80% stake in French IT consulting firm AOSIS, enhancing its expertise in SAP, Data, Cloud, and smart solutions tailored for the aerospace, aviation, and transportation industries. Looking ahead, FPT aims to be among the Top 50 IT companies in France, targeting to expand its local workforce to over 500 experts and its presence in France and neighbouring Francophone countries.
About FPT
FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of USD 2.17 billion and 48,000+ employees. For more information about global IT services, please visit https://fptsoftware.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211227891/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom